Inventor
DROGUETT GUSTAVO
US13 patents
⚠️ This page may combine multiple inventors who share the name “DROGUETT GUSTAVO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
12 patentsUS10106820B2Oct 23, 2018
Methods and compositions for modifying a targeted locus
REGENERON PHARMA6 citations83
US9902971B2Feb 27, 2018
Methods for producing a mouse XY embryonic (ES) cell line capable of producing a fertile XY female mouse in an F0 generation
REGENERON PHARMA5 citations83
US10781453B2Sep 22, 2020
Non-human animals having a hexanucleotide repeat expansion in a C9ORF72 locus
REGENERON PHARMA6 citations79
US10457960B2Oct 29, 2019
Methods and compositions for targeted genetic modification using paired guide RNAs
REGENERON PHARMA5 citations73
US10294494B2May 21, 2019
Methods and compositions for modifying a targeted locus
REGENERON PHARMA2 citations72
US10023916B2Jul 17, 2018
Markers of tumor cell response to anti-cancer therapy
REGENERON PHARMA5 citations72
US10793874B2Oct 6, 2020
Methods and compositions for targeted genetic modifications and methods of use
REGENERON PHARMA4 citations71
US11697828B2Jul 11, 2023
Methods and compositions for targeted genetic modification using paired guide RNAs
REGENERON PHARMA1 citations62
US12060571B2Aug 13, 2024
Methods and compositions for modifying a targeted locus
REGENERON PHARMA1 citations61
US12041918B2Jul 23, 2024
Production of fertile XY female animals by silencing of genes on the Y chromosome
REGENERON PHARMA0 citations59
US10893666B2Jan 19, 2021
Production of fertile XY female animals by silencing of genes on the Y chromosome
REGENERON PHARMA1 citations59
US12342801B2Jul 1, 2025
Methods for producing antigen-binding proteins against foreign antigens
REGENERON PHARMA0 citations49